Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Drug Delivery: Parenteral Route

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.

Journal of Alzheimer's disease : JAD·2020

Same author

Translatability of the S7A core battery respiratory safety pharmacology studies: Preclinical respiratory and related clinical adverse events.

Journal of pharmacological and toxicological methods·2019

Same author

Pharmacokinetics in Rat of P8, a Peptide Drug Candidate for the Treatment of Alzheimer's Disease: Stability and Delivery to the Brain.

Journal of Alzheimer's disease reports·2018

Same author

Evaluating cardiac risk: exposure response analysis in early clinical drug development.

Drug, healthcare and patient safety·2018

Same author

Tracking the Sugar Rush: Incorporating Continuous Glucose Monitoring Into Multisite Early Clinical Research With Type 2 Diabetes Subjects.

Clinical pharmacology in drug development·2018

Same author

Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines.

Expert review of clinical pharmacology·2016

Search research articles

Related Experiment Video

Updated: Feb 22, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Therapeutic peptides for CNS indications: Progress and challenges.

Bruce H Morimoto¹

¹Scientific Affairs, Celerion, Inc., 621 Rose Street, Lincoln, NE 68502, USA.

Bioorganic & Medicinal Chemistry

|September 28, 2017

Summary

New peptide therapeutics offer a novel approach to treating neurodegenerative diseases like Alzheimer's and stroke. By targeting protein interactions, these CNS peptides aim for better safety and efficacy than traditional small molecules.

More Related Videos

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Related Experiment Videos

Last Updated: Feb 22, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Area of Science:

Neuroscience
Pharmacology
Drug Development

Background:

Neurodegenerative diseases, including Alzheimer's disease and stroke, represent significant unmet medical needs with high rates of drug development failure.
Traditional small molecule approaches targeting key proteins like NMDA receptor, gamma-secretase, and cyclin-dependent kinase have faced challenges due to severe on-target side effects.

Purpose of the Study:

This review highlights three central nervous system (CNS) peptide programs.
These programs aim to overcome the limitations of small molecule therapeutics in treating neurodegenerative conditions.

Main Methods:

Focuses on CNS peptide therapeutics targeting specific protein-protein interactions.
Examines interventions for NMDA receptor, gamma-secretase, and cyclin-dependent kinase pathways.

Main Results:

Peptide-based interventions disrupt selective protein-protein interactions, offering an alternative to direct target inhibition.
This approach aims to mitigate the severe side effects associated with traditional small molecule drugs.

Conclusions:

CNS peptide programs present a promising strategy for developing safer and more effective therapeutics for neurodegenerative diseases.
Targeting protein interactions offers a novel pathway to address challenging neurological indications.